Category Archives: announcement

Enrollment continues rolling for COPD Study

Nearly 100 people have enrolled in the MURDOCK COPD Study, an observational study that is collecting information on the current level of symptoms, as well as ability to breathe, treatment, and outcomes of people with Chronic Obstructive Pulmonary Disease (COPD).
The study will enroll 850 people and follow the progression of the disease over five years. Participants are not required to already be enrolled in the MURDOCK Study or live in a certain zip code to qualify. To learn more, please click here.

MURDOCK Study now part of Duke CTSI

Duke’s Kannapolis office and the MURDOCK Study are proud to be part of the new Duke Clinical & Translational Science Institute (CTSI), an academic hub for accelerating the translation and implementation of scientific discoveries into health benefits for patients and communities.
L. Kristin Newby, MD, MHS, principal investigator for the MURDOCK Study, is the faculty lead for the CTSI’s Translational Population Health Research Group. The CTSI strives to overcome the obstacles to developing discoveries into devices, drugs, or therapies to improve health. The CTSI collaborates with schools, departments, denters and programs across Duke. To learn more about the CTSI, click here.

Duke University names new director of operations for MURDOCK Study, related research projects

Julie Eckstrand, R.Ph., has been named the new director of operations for Duke University’s Translational Population Health Research Group, which includes the MURDOCK Study and Duke’s other clinical research studies based at the North Carolina Research Campus (NCRC) in Kannapolis.

In her new role, Eckstrand will manage operations for the “TransPop” Group for the new Duke Clinical and Translational Science Institute (CTSI).  The research portfolio includes the MURDOCK Study and related research projects involving biomarkers, longitudinal registries, risk modeling of data, and community-engaged research at the Duke-Kannapolis office. TransPop serves as an academic hub for accelerating the translation and implementation of scientific discoveries into health benefits for patients and communities. Continue reading Duke University names new director of operations for MURDOCK Study, related research projects

Duke Staff Dance to Raise Awareness of Diabetes

 

Faculty and staff from Duke Endocrinology and Duke’s office in Kannapolis are kicking up their heels on the dance floor to raise awareness of diabetes and diabetes research.

The #DiabetesDanceDare is a social media challenge created by the American Diabetes Association (ADA) for National Diabetes Awareness Month in November, but the “dare” will continue well into 2017. Organizations, advocacy group and individuals across the country are posting videos of themselves dancing for 23 seconds to represent the rate of diabetes diagnoses in the U.S. — a new diagnosis every 23 seconds. Continue reading Duke Staff Dance to Raise Awareness of Diabetes

MURDOCK Study celebrates MS enrollment closeout

The MURDOCK Study celebrated the enrollment closeout of the MURDOCK Multiple Sclerosis (MS) Study with participants and researchers at the NC Research Campus. The event included the launch of Discovery MS by the David H. Murdock Research Institute (DHMRI) and Simon Gregory, PhD. Discovery MS is a new initiative housed in the DHMRI that will continue advancing MS research using the MURDOCK Study’s biological samples and data. To view photos from the event, click here. Continue reading MURDOCK Study celebrates MS enrollment closeout

MURDOCK Study results featured in Wall Street Journal

Findings from the MURDOCK Health Aging Study were included in a Wall Street Journal article featuring Dr. Miriam Morey, MURDOCK Study investigator and Duke University School of Medicine professor, and Dr. Katherine Hall, assistant professor of medicine at Duke and first author of the paper about the research. Excerpts from the article include: Continue reading MURDOCK Study results featured in Wall Street Journal